Julie Hallet, Director of Research at Canadian Society of Surgical Oncology, shared a post on X:
“Defining high-risk pancreas NETs
496 resections
Early recurrence
71% if venous thrombosis
41% if Ki 67>5% + tumor >3cm + LN
Signs of biologically borderline-resectable NETs
before resection, start with systemic drugs.”
Title: Defining Biological Borderline Resectable Non-Functioning Pancreatic Neuroendocrine Tumors (NF-PanNETs): A Predictive Model for Preoperative Assessment of Early Recurrence Risk
Authors: Stefano Partelli, Giovanni Guarneri, Paola Rancoita, Ino De Martino, Lorenzo Provinciali, Louis De Mestier, Safi Dokmak, Julie Hallet, Alain Sauvanet, Massimo Falconi,
Read More About Pancreatic NETs on OncoDaily.
